Active Recombinant Human FAM19A4

• Cat.No.: FAM19A4-632H
• Product Overview: Recombinant Human FAM19A4 (Accession # NP_001005527) Ser35-Arg140 was produced in E. coli-derived.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Ser35
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to enhance neurite outgrowth of E16-E18 rat embryonic cortical neurons.rhTAFA4, immobilized at 6 - 24 µg/mL on a 96-well plate, is able to significantly enhance neurite outgrowth.
• Molecular Mass: Recombinant Human FAM19A4 has a calculated MW of 11.7 kDa. In SDS-PAGE migrates as 11 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: FAM19A4 family with sequence similarity 19 (chemokine (C-C motif)-like), member A4 [ Homo sapiens ]
• Official Symbol: FAM19A4
• Synonyms: FAM19A4; family with sequence similarity 19 (chemokine (C-C motif)-like), member A4; protein FAM19A4; TAFA 4; chemokine-like protein TAFA-4; TAFA4; TAFA-4; FLJ25161
• Gene ID: 151647
• mRNA Refseq: NM_001005527
• Protein Refseq: NP_001005527
• UniProt ID: Q96LR4
• Chromosome Location: 3p14.1